5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy https://www.biorxiv.org/content/10.1101/2023.02.03.526871v1?med=mas
5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy https://www.biorxiv.org/content/10.1101/2023.02.03.526871v1?med=mas